ARCHIVES

IOM Committee Will Probe Duke Scandal Together With Other “Omics” Case Studies

This article is from The Cancer Letter archive.

Vol. 37 No. 01 | January 7, 2011

Download PDF Visit The Full Archive

Related Articles

Also HHS Inspector General is reviewing Lester Crawford’s departure from FDA.

October 28, 2005

This month’s 8-page Business & Regulatory Report included in this issue.

January 30, 2004

For NCI ; Scharff Succeeds Eagle At Einstein

September 25, 1987

Another HHS Recommendation: Screen 50 And Older For Colorectal Cancer;

March 15, 2002

VeriStrat Biomarker Test Predicts Treatment Outcomes In Phase III NSCLC Trial

May 30, 2014

Phase III Nexavar Trial Fails Primary Endpoint

August 29, 2014